TABLE 2.
Clinical Endpoint | Cox Regression Factor | Number at Risk (%) | HR (95% CI) | p |
---|---|---|---|---|
Loss of ambulation | Corticosteroids | 26 (30) | 0.69 (0.35–1.34) | 0.270 |
Ataluren | 6 (7) | 0.66 (0.18–2.36) | 0.520 | |
Residual dystrophin | 47 (53) | 0.05 (0.02–0.12) | <0.001 | |
LVEF < 30% | Corticosteroids | 19 (26) | 0.92 (0.11–7.53) | 0.938 |
ACE inhibitors | 56 (77) | 0.57 (0.10–3.37) | 0.535 | |
Residual dystrophin | 34 (47) | 0.29 (0.06–1.43) | 0.127 |
ACE = angiotensin‐converting enzyme; CI = confidence interval; HR = hazard ratio; LVEF = left ventricular ejection fraction.